D.E. Shaw & Co
PLXP

D.E. Shaw & Co’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

D.E. Shaw & Co’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-64,556
Closed -$157K – 5698
2022
Q2 		$157K Sell
64,556
-47,069
-42% -$131K ﹤0.01% 4621
2022
Q1 		$451K Buy
+111,625
New +$612K ﹤0.01% 4434

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

D.E. Shaw & Co's PLXP Position: Q3 2022 in Review

D.E. Shaw & Co sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2022, closing a stake of 64,556 shares — an estimated $157K sold.

D.E. Shaw & Co first reported a position in PLXP in Q1 2022 and held it in 2 quarters. The position peaked at $451K in Q1 2022. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

  • D.E. Shaw & Co reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 64,556 PLx Pharma Inc. Common Stock shares in Q3 2022, an estimated $157K.
  • D.E. Shaw & Co first reported a position in PLx Pharma Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • D.E. Shaw & Co's PLx Pharma Inc. Common Stock position peaked at $451K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.